PT - JOURNAL ARTICLE AU - Jiahao Liu AU - Viji Nair AU - Yi-yang Zhao AU - Dong-yuan Chang AU - Felix Eichinger AU - Emily C. Tanner AU - Damian Fermin AU - Keith A. Bellovich AU - Susan Steigerwalt AU - Zeenat Bhat AU - Jennifer J. Hawkins AU - Lalita Subramanian AU - Sylvia E. Rosas AU - John R. Sedor AU - Miguel A. Vasquez AU - Sushrut S. Waikar AU - Markus Bitzer AU - Subramaniam Pennathur AU - Frank Brosius AU - Min Chen AU - Matthias Kretzler AU - Wenjun Ju AU - for the Kidney Precision Medicine Project and Michigan Translational Core C-PROBE Investigator Group TI - Multi-scalar data integration links glomerular angiopoietin-tie signaling pathway activation with progression of diabetic kidney disease AID - 10.1101/2021.12.21.21267377 DP - 2022 Jan 01 TA - medRxiv PG - 2021.12.21.21267377 4099 - http://medrxiv.org/content/early/2022/01/14/2021.12.21.21267377.short 4100 - http://medrxiv.org/content/early/2022/01/14/2021.12.21.21267377.full AB - Diabetes is the leading cause of chronic kidney disease. Prognostic biomarkers reflective of underlying molecular mechanisms are critically needed for effective management of diabetic kidney disease (DKD). In the Clinical Phenotyping and Resource Biobank study, an unbiased, machine learning approach identified a three-marker panel from plasma proteomics which, when added to standard clinical parameters, improved the prediction of outcome of end-stage kidney disease (ESKD) or 40% decline in baseline glomerular filtration rate (GFR) in a discovery DKD group (N=58) and was validated in an independent group (N=68) who also had kidney transcriptomic profiles available. Of the three markers, plasma angiopoietin 2 (ANGPT2) remained significantly associated with composite outcome in 210 Chinese Cohort Study of Chronic Kidney Disease participants with DKD. The glomerular transcriptional Angiopoietin/Tie (ANG-TIE) activation scores, derived from the expression of 154 literature-curated ANG-TIE signaling mediators, positively correlated with plasma ANGPT2 levels and outcome, explained by substantially higher TEK receptor expression in glomeruli and higher ANG-TIE activation scores in endothelial cells in DKD by single cell RNA sequencing. Our work suggests that activation of glomerular ANG-TIE signaling in the kidneys underlies the association of plasma ANGPT2 with disease progression, thereby providing potential targets to prevent DKD progression.Competing Interest StatementDr. M. Kretzler reports grants from NIH/NIDDK in support of this manuscript. Grants and contracts outside the submitted work through the University of Michigan with NIH, Chan Zuckerberg Initiative, JDRF, AstraZeneca, NovoNordisk, Eli Lilly, Gilead, Goldfinch Bio, Janssen, Boehringer-Ingelheim, Moderna, European Union Innovative Medicine Initiative, Certa, Chinook, amfAR, Angion, RenalytixAI, Travere, Regeneron, IONIS, consulting fees through the University of Michigan from Astellas, Poxel, Janssen. In addition, Dr. Kretzler has a patent PCT/EP2014/073413 licensed. Dr. Rosas reports grants from NIH/NIDDK in support of this manuscript, grants, and contracts through the Joslin Diabetes Center with NIDDK, Bayer, and AstraZeneca. Funding StatementThis work was supported by a grant from the University of Michigan Health System and Peking University Health Sciences Center Joint Institute for Translational and Clinical Research (No. BMU2017JI001). Support provided by the China Scholarship Council (201906370288) during a visit of JL to University of Michigan is acknowledged. This study was also supported, in part, by funding from NIH/NIDDK through the George M. OBrien Michigan Kidney Translational Core Center, grant 2P30-DK-081943; the Integrated Systems Biology Approach to Diabetic Microvascular Complications grant, R24DK082841; P30DK89503; and JDRF Center for Excellence (5-COE-2019-861-S-B). The Kidney Precision Medicine Project (KPMP), UH3-DK-114907, is a multi-year project funded by the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) with the purpose of understanding and finding new ways to treat chronic kidney disease (CKD) and acute kidney injury (AKI). See Supplemental Acknowledgments for consortium details. C-STRIDE is supported by a grant from China International Medical Foundation-Renal Anemia Fund, the grants from the National Natural Science Found (No. 82070748, 82090020 and 82090021). Dr. Vasquez is supported through funds from the National Institutes of Health, 5UH3DK114870-05. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The C-PROBE study is approved by the University of Michigan IRB. The C-STRIDE study was approved by the ethics committee of Peking University First Hospital.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the present study can be made available through appropriate approvals from cohort study committees. Transcriptomic data were also accessed through GEO: GSE142025, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180395 https://atlas.kpmp.org/repository https://www.nephroseq.org/ TItubulointerstitialATLascending thin loop of HenleCNTconnecting tubuleDCTdistal convoluted tubuleDTLdescending loop of HenleECendothelial cellFIBfibroblastICintercalated cellLOHloop of HenleMCmesangial cellMYLmyeloid cellPCprincipal cellPECparietal epithelial cellPODpodocytePTproximal tubular epithelial cellTALthick ascending loop of HenleVSMCvascular smooth muscle cell